| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,870 |
17,373 |
$2.90M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,772 |
1,670 |
$118K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,682 |
1,572 |
$77K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
189 |
181 |
$58K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
882 |
874 |
$52K |
| 87634 |
|
655 |
634 |
$45K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
602 |
595 |
$36K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
374 |
360 |
$25K |
| 87400 |
|
539 |
534 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
65 |
64 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
40 |
39 |
$734.40 |
| 87070 |
|
39 |
38 |
$202.98 |
| 71046 |
Radiologic examination, chest; 2 views |
14 |
14 |
$175.04 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$161.49 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
12 |
$0.00 |